Algernon Pharmaceuticals Inc. (AGNPF)
USD 0.05
(3.65%)
USD 0.05
(3.65%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -50.39 Thousand CAD | -44.26% |
| 2022 | -34.93 Thousand CAD | 0.0% |
| 2021 | - CAD | 0.0% |
| 2020 | - CAD | 100.0% |
| 2019 | -26.99 Thousand CAD | 34.08% |
| 2018 | -40.95 Thousand CAD | 67.89% |
| 2017 | -127.53 Thousand CAD | -165.92% |
| 2016 | -47.96 Thousand CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -7642.00 CAD | -2.88% |
| 2024 Q3 | -6085.00 CAD | 20.37% |
| 2024 Q1 | -7428.00 CAD | 44.31% |
| 2023 Q1 | -11.69 Thousand CAD | 58.81% |
| 2023 Q4 | -13.33 Thousand CAD | -3.95% |
| 2023 FY | -50.39 Thousand CAD | -44.26% |
| 2023 Q3 | -12.83 Thousand CAD | -2.36% |
| 2023 Q2 | -12.53 Thousand CAD | -7.23% |
| 2022 Q1 | - CAD | 0.0% |
| 2022 Q4 | -28.38 Thousand CAD | -1343.64% |
| 2022 Q3 | -1966.00 CAD | 57.15% |
| 2022 Q2 | -4588.00 CAD | 0.0% |
| 2022 FY | -34.93 Thousand CAD | 0.0% |
| 2021 Q4 | - CAD | 0.0% |
| 2021 Q3 | - CAD | 0.0% |
| 2021 FY | - CAD | 0.0% |
| 2021 Q2 | - CAD | 0.0% |
| 2021 Q1 | - CAD | 0.0% |
| 2020 Q2 | - CAD | 0.0% |
| 2020 FY | - CAD | 100.0% |
| 2020 Q3 | - CAD | 0.0% |
| 2020 Q4 | - CAD | 0.0% |
| 2020 Q1 | - CAD | 0.0% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 Q2 | - CAD | 0.0% |
| 2019 Q1 | - CAD | 0.0% |
| 2019 FY | -26.99 Thousand CAD | 34.08% |
| 2019 Q3 | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 FY | -40.95 Thousand CAD | 67.89% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 FY | -127.53 Thousand CAD | -165.92% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 FY | -47.96 Thousand CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Bioxytran, Inc. | -8285.00 USD | -508.304% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 100.336% |
| Institute of Biomedical Research Corp. | - USD | Infinity% |
| SQZ Biotechnologies Company | 9.79 Million USD | 100.515% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | 176.677% |
| Evofem Biosciences, Inc. | 11.7 Million USD | 100.431% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 100.042% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | -47.578% |
| Marizyme, Inc. | 457.7 Thousand USD | 111.011% |
| Genus plc | 178.7 Million USD | 100.028% |
| Pharming Group N.V. | 220.1 Million USD | 100.023% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | 180.992% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | 112.287% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | -358.164% |
| ContraFect Corporation | -154 Thousand USD | 67.274% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | 165.656% |
| IMV Inc. | -962.29 Thousand USD | 94.763% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 86.994% |
| ONE Bio Corp. | 20.12 Million USD | 100.25% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 100.125% |
| Mesoblast Limited | -35.16 Million USD | 99.857% |
| MultiCell Technologies, Inc. | 49.32 USD | 102285.726% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 100.178% |
| Genscript Biotech Corporation | 409.55 Million USD | 100.012% |
| Neon Bloom, Inc. | - USD | Infinity% |
| Mosaic ImmunoEngineering Inc. | - USD | Infinity% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | 1724.694% |
| Biomind Labs Inc. | -15.42 Thousand USD | -226.751% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 95.585% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | 171.997% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 59.439% |
| GlobeStar Therapeutics Corporation | - USD | Infinity% |
| VioQuest Pharmaceuticals, Inc. | - USD | Infinity% |
| THC Farmaceuticals, Inc. | -4952.00 USD | -917.73% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | -0.796% |
| Arch Therapeutics, Inc. | -2439.00 USD | -1966.339% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | 135.87% |
| Accustem Sciences Inc. | - USD | Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | 203.063% |
| Q BioMed Inc. | -8988.00 USD | -460.725% |
| GB Sciences, Inc. | -624.00 USD | -7976.603% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 41.417% |
| CSL Limited | 7.56 Billion USD | 100.001% |
| Agentix Corp. | - USD | Infinity% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 100.114% |
| Enzolytics Inc. | 30.7 Thousand USD | 264.12% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Resverlogix Corp. | - USD | Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | 110.447% |
| MetaStat, Inc. | - USD | Infinity% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 48.318% |
| argenx SE | 1.1 Billion USD | 100.005% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 99.805% |
| HST Global, Inc. | - USD | Infinity% |
| Enzon Pharmaceuticals, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | - USD | Infinity% |
| Halberd Corporation | -208.00 USD | -24129.808% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 90.205% |
| Inhibitor Therapeutics, Inc. | - USD | Infinity% |
| Zenith Capital Corp. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | Infinity% |
| GeneThera, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | -469.083% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | 108.163% |
| WPD Pharmaceuticals Inc. | - USD | Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 39.894% |
| Ember Therapeutics, Inc. | - USD | Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Adynxx, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | 105.101% |
| Capstone Therapeutics Corp. | 9.61 Million USD | 100.524% |
| Kadimastem Ltd | -630.13 Thousand USD | 92.002% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| BioStem Technologies, Inc. | 15.42 Million USD | 100.327% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | - USD | Infinity% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| LadRx Corporation | -11.83 Thousand USD | -325.839% |
| Cell Source, Inc. | - USD | Infinity% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | -4.432% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 128.544% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 128.544% |
| Affymax, Inc. | 1.35 Million USD | 103.714% |
| Mobile Lads Corp. | - USD | Infinity% |
| Itoco Inc. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | - USD | Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | 101.094% |
| CytoDyn Inc. | -29 Thousand USD | -73.786% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | - USD | Infinity% |
| NanoSphere Health Sciences Inc. | - USD | Infinity% |
| Qrons Inc. | - USD | Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | 111.198% |
| SYBLEU INC | 11.69 Thousand USD | 530.899% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 84.226% |
| Rebus Holdings, Inc. | - USD | Infinity% |
| GlobeImmune, Inc. | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | - USD | Infinity% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | - USD | Infinity% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | - USD | Infinity% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | - USD | Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 86.488% |
| Neutra Corp. | 14.33 Thousand USD | 451.573% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 38.539% |
| PureTech Health plc | -1.6 Million USD | 96.856% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 94.966% |
| IXICO plc | 3.27 Million USD | 101.541% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 92.738% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 97.186% |
| CSL Limited | 7.7 Billion USD | 100.001% |
| Cellectis S.A. | 18 Thousand USD | 379.989% |